Canada Launches ‘More Responsive’ Post-Marketing Drug Evaluation Program
Canada’s health technology appraisal body, CADTH, has launched a new program that will harness real-world evidence to provide more information and advice on the safety and effectiveness of drugs that are already approved.
You may also be interested in...
Industry representatives are invited to join a new task force to help advise on how industry-gathered real-world evidence should be used in regulatory and health technology assessment decision making.
Canada’s health technology appraisal body is seeking feedback on guidance on the use of real-world evidence in decision making.
Important updates to good manufacturing practice guidelines are likely to mean medicine shortages, warns a German pharmaceutical industry group.